The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer

被引：7
|
作者：
Santana-Davila, Rafael [1 ]
Chow, Laura Q. M. [1 ]
机构：
[1] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA
来源：
FUTURE ONCOLOGY | 2018年 / 14卷 / 03期
关键词：
chemo-immunotherapy; first-line; immune checkpoint inhibitors; immunotherapy; lung cancer; NSCLC; treatment naive; PACLITAXEL PLUS CARBOPLATIN; OPEN-LABEL; PHASE-III; PEMBROLIZUMAB; NIVOLUMAB; DOCETAXEL; CHEMOTHERAPY; MULTICENTER; IPILIMUMAB;
D O I：
10.2217/fon-2017-0124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：191 / 194
页数：4
相关论文
共 50 条
  • [31] PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer
    Papadaki, C.
    Sfakianaki, M.
    Lagoudaki, E.
    Giagkas, G.
    Ioannidis, G.
    Trypaki, M.
    Tsakalaki, E.
    Voutsina, A.
    Koutsopoulos, A.
    Mavroudis, D.
    Georgoulias, V.
    Souglakos, J.
    BRITISH JOURNAL OF CANCER, 2014, 111 (09) : 1757 - 1764
  • [32] Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer
    Bajetta, E
    Stani, SC
    De Candis, D
    Zaffaroni, N
    Zilembo, N
    Cortinovis, D
    Aglione, S
    Mariani, L
    Formisano, B
    Bidoli, P
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 242 - 247
  • [33] Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin
    Kakolyris, S
    Kouroussis, C
    Kalbakis, K
    Mavroudis, D
    Souglakos, J
    Vardakis, N
    Kremos, S
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2000, 11 (06) : 757 - 760
  • [34] PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer
    C Papadaki
    M Sfakianaki
    E Lagoudaki
    G Giagkas
    G Ioannidis
    M Trypaki
    E Tsakalaki
    A Voutsina
    A Koutsopoulos
    D Mavroudis
    V Georgoulias
    J Souglakos
    British Journal of Cancer, 2014, 111 : 1757 - 1764
  • [35] Targeted therapy for non-small-cell lung cancer
    Rasul, K. T.
    Al-Khater, A. M.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2010, 40 (03): : 221 - 221
  • [36] Adjuvant therapy for non-small-cell lung cancer
    Kalemkerian, Gregory P.
    LANCET, 2010, 375 (9722): : 1230 - 1231
  • [37] Targeted therapy for non-small-cell lung cancer
    Belani, CP
    LUNG CANCER, 2004, 45 : S7 - S7
  • [38] Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer
    Stinchcombe, Thomas E.
    Borghaei, Hossein
    Barker, Scott S.
    Treat, Joseph Anthony
    Obasaju, Coleman
    CLINICAL LUNG CANCER, 2016, 17 (01) : 1 - 9
  • [39] Systemic therapy in non-small-cell lung cancer
    Jazieh, Abdul-Rahman
    Saadeen, Ahmed
    ANNALS OF THORACIC MEDICINE, 2008, 3 (06) : S97 - S99
  • [40] Maintenance therapy in non-small-cell lung cancer
    Schmid-Bindert, Gerald
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (02) : 105 - 110
12345